Nhs Framework for the North of England, Branded Me...

Get Access to 1 Million Global Tenders

You are Successfully Registered to zimbabwetenders!!

Email Id is already exist !!

Something went wrong !!

Download Tender Documents

Country: United Kingdom
Summary: Nhs Framework for the North of England, Branded Medicines - Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)
GBT Ref No: 57435955
Deadline: 20 Oct 2021
Competition: ICB
Financier: Self Financed
Purchaser Ownership: -
Tender Value: 431955441
Notice Type: Tender
Document Ref. No.: CF-0346100D0O000000rwimUAA1
Purchaser's Detail :

Purchaser : NHS ENGLAND
2nd Floor Rutland House Runcorn WA7 2ES UK
Contact Person : Giorgie Rushton
Email :giorgie.rushton2@nhs.net

Description :
Title : NHS Framework for the North of England, Branded Medicines - Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)
Location Of Contract : WA7 2ES
Industry : Pharmaceutical products - 33600000
Value Of Contract : £431,955,441
Description : Offer reference number: CM/PHR/20/5600CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 monthsCM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), Midlands and East - Period...
Documents :